Celgene Enters Strategic Collaboration With Nimbus Therapeutics
New Jersey-based Celgene has now established a long-term strategic alliance with Private biotech Nimbus Therapeutics for two pre-clinical assets,...
DNA-Based Zika Vaccine Found To Be Safe In First Human Trail
Zika virus is a mosquito-borne infection associated with birth defects and neurological complications in...
CRISPR-Gold Found To Fix Duchenne Dystrophy Mutation In Mouse
The functions of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and CRISPR-associated (Cas) genes are essential...
Peter Thiel and Sean Parker of PayPal Are Backing A Stealth Start-Up
PayPal founder Peter Thiel and Facebook investor Sean Parker are investing in a...
Inhibition Of Hippo Pathway Found To Reverse Heart Failure
Mammalian organs vary widely in regenerative capacity. Poorly regenerative organs, such as the heart are particularly...
Amgen Announces Alliance With Simcere To Commercialize Biosimilars
US-based biotechnology company Amgen has now announced a strategic collaboration with Simcere Pharmaceutical Group, a R&D-driven Chinese...
JRF Job @ JIPMER | MSc & M.Tech Candidates Eligible for DHR Research Project
Applications are invited from qualified candidates for the following post for...
14 Kerala State Young Scientist Award - KSCSTE | Applications Online
KSCSTE is in the process of e-office implementation with effect from 01.08.2017. Therefore all...
PhD Admissions NISER 2018 - Official Notification
NATIONAL INSTITUTE OF SCIENCE EDUCATION AND RESEARCH
BHUBANESWAR
Advt.No:NISER/ACAD/Ph.D/2017-18(2)
Notice for Admission to Ph.D. Programme – 2018 (Winter Session)
Applications are...
Revised Dates & Eligibility Criteria for SERB - NPDF/ECRA/EMR Programs
Revised dates for call for proposal under different schemes and programs.............. Read More
Govt Job @ CDSA...
Revised Dates & Eligibility Criteria for SERB - NPDF/ECRA/EMR Programs
SCIENCE AND ENGINEERING RESEARCH BOARD
(Statutory Body Established through an Act of Parliament: SERB Act 2008)
Under...
EU Approves Janssen’s Single-Tablet HIV Regimen Symtuza
The European Commission (EC) has now approved the use of Symtuza- Janssen’s once-daily pill for human immunodeficiency virus...
Abivax’s HIV Cure Candidate Presents Positive Phase 2a - Virus
Paris-based biotech, Abivax has now announced top-line results from the first cohort of Phase 2a...
Oxford Spinout, Nightstar Therapeutics Debuts On Nasdaq With $75M IPO
Since the mutation causing Choroideremia is sex-linked, sufferers are almost always males, with the onset...
New Spin-Out Biotech To Advance Alternative Menopause Treatment
U.K. biotech NeRRe Therapeutics has now spun out KaNDy Therapeutics, a company focusing on women’s health. The...
